Filing Flows › Outset Medical (OM) › Q2 2025
Outset Medical (OM) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Outset Medical (OM) reported revenue of $31.4M for the second quarter 2025 (Q2 2025), +15% from a year earlier and +6% from the quarter before. Operating margin was -53.7%, net loss $18.5M (59.0% of revenue).
Outset Medical, Q2 2025: revenue $31.4M (+15% year over year), operating margin -53.7%, net loss $18.5M, operating cash flow −$4.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.4M | +6% | +15% |
| Operating profit | −$16.9M | — | — |
| Net earnings | −$18.5M | — | — |
| Operating cash flow | −$4.8M | — | — |
What changed
Revenue was $31.4M in Q2 2025, up 15% year over year and up 6% from the previous quarter. Consumables Product was the largest line at 45% of revenue. Consumables Product added $2.1M year over year (up 17%), 51% of the total change.
Gross margin was 37.8%, up 2.1 points from a year earlier. Operating costs exceeded revenue by $16.9M, an operating margin of -53.7%. Operating expenses fell 29% while revenue rose 15%. The quarter ended with a net loss of $18.5M, narrower than the previous quarter's $25.8M loss.
Operating cash flow was −$4.8M. Non-cash charges added back $1.2M of depreciation and amortization and $3.5M of share-based compensation. Working capital and other items added $9.1M. Capital expenditures of $292K exceeded it, leaving free cash flow of −$5.1M.
Questions
What was Outset Medical's revenue in the second quarter 2025?
Outset Medical (OM) reported revenue of $31.4M for the second quarter 2025 (Q2 2025), +15% from a year earlier and +6% from the quarter before.
Was Outset Medical profitable in the second quarter 2025?
Operating loss was $16.9M (-53.7% of revenue) and net loss $18.5M.
Source: Outset Medical 10-Q on SEC EDGAR.